Child-Pugh Score for Cirrhosis Mortality

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۵۰ • واحد: mg/dL

حداقل ۱ — حداکثر ۵ • واحد: g/dL

حداقل ۰.۸ — حداکثر ۱۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
child pugh score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • —5–6
  • —7–9
  • —10–15

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Hepatology, Alcoholic Hepatitis & GI Bleeding — بیماری‌های کبدی، هپاتیت الکلی و خونریزی گوارشی

Clinical Rationale:

Assess chronic liver failure with Child-Pugh, MELD, and MELD-Na; evaluate alcoholic hepatitis severity with Maddrey and GAHS for steroid indication, and triage upper GI bleeding with Glasgow-Blatchford and AIMS65.

Recommended Clinical Next Steps:

  • MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)

    امتیاز MELD کلاسیک

    Why next: End-stage liver disease severity baseline
  • MELD Na (UNOS/OPTN)

    امتیاز MELD-Na (UNOS/OPTN)

    Why next: Liver transplant allocation priority with sodium
  • Maddrey's Discriminant Function for Alcoholic Hepatitis

    تابع مادری برای هپاتیت الکلی

    Why next: Corticosteroid indication in alcoholic hepatitis
Direct Clinical Answer

The Child-Pugh Score for Cirrhosis Mortality calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include total bilirubin. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates severity of cirrhosis and prognosis in patients with chronic liver disease

Clinical Indication

The Child-Pugh Score for Cirrhosis Mortality is indicated for bedside clinical practice to support Estimates severity of cirrhosis and prognosis in patients with chronic liver disease. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.

Formula & Variables:

Score = Bilirubin points + Albumin points + INR points + Ascites points + Encephalopathy points

Input Parameters

NameTypeRequiredDescription
total_bilirubinfloatYesSerum total bilirubin level(mg/dL)
serum_albuminfloatYesSerum albumin level(g/dL)
inrfloatYesInternational Normalized Ratio (INR)
ascitesstringYesPresence and severity of ascites
encephalopathystringYesHepatic encephalopathy grade

Score Interpretation & Guidance

RangeStageDescription
5–6—Well-compensated disease
7–9—Significant functional compromise
10–15—Decompensated disease

Evidence-Based References (EBM)

  • Child CG, Turcotte JG. Surgery and portal hypertension. In: The liver and portal hypertension. Edited by CG Child. Philadelphia: Saunders 1964:50-64.
  • Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646-9.
  • Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008 Feb;28(1):110-22.

Related calculators